论文部分内容阅读
目的 比较研究胰岛素泵皮下持续注射胰岛素治疗(CSⅡ) 和常规皮下注射胰岛素治疗(MDI)分别对血糖控制较差糖尿病的疗效。方法 采用对照研究方法比较两者的血糖、胰岛素总量、血糖达标时间。结果CSⅡ治疗组空腹血糖及餐后2小时血糖均明显下降, 胰岛素总量少, 达标时间缩短。结论 对于血糖控制不理想患者使用CSⅡ治疗可使血糖尽快达标, 减轻葡萄糖毒性作用, 减少胰岛素用量, 为长期血糖控制不良患者的临床治疗提供了一种更有效的方法。
Objective To compare the efficacy of continuous subcutaneous insulin pump (CS Ⅱ) and conventional subcutaneous insulin injection (MDI) on poor glycemic control of diabetic patients. Methods A comparative study was conducted to compare the blood glucose, total insulin and blood glucose time. Results The fasting blood glucose and postprandial 2-hour postprandial blood glucose in CSⅡ treatment group were significantly decreased, with less total insulin and shortened standard time. Conclusion CSⅡ treatment for patients with unsatisfactory glycemic control can make the blood glucose reach the standard as soon as possible, reduce the toxic effects of glucose and reduce the dosage of insulin, which provides a more effective method for the clinical treatment of patients with long-term adverse glycemic control.